Will the FDA approve any psychedelic substance for medical use this year?

Before 2027 If the FDA approves Any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes. Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA,, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca. This market will close and expire early if the event occurs.